Advertisement

Reactions Weekly

, Volume 1696, Issue 1, pp 205–205 | Cite as

Infliximab

Drop in systolic BP: case report
Case report
  • 29 Downloads

Reference

  1. Robinson K, et al. Accelerated infusions of biosimilar infliximab are safe and well tolerated and monitoring post-infusion is not required. Journal of Crohn's and Colitis 11 (Suppl. 1): S492-S493, Feb 2017. Available from: URL: http://doi.org/10.1093/ecco-jcc/jjx002.927 [abstract] - United KingdomCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations